Browse EX-10 agreements

CONFIDENTIAL SETTLEMENT AGREEMENT

This Confidential Settlement Agreement (the “Agreement”), dated September 4, 2026 is entered into by and among Cardlytics, Inc. (“Cardlytics”) and Amit Jain (“Mr. Jain”). Cardlytics and Mr. Jain shall each be referred to herein as a “Settling Party,” and collectively as the “Settling Parties.”

WHEREAS, on November 20, 2014, Bridg, Inc. (“Bridg”) entered into a Director Indemnification Agreement with Mr. Jain (the “Indemnification Agreement”);

WHEREAS, on April 12, 2021, Cardlytics executed an Agreement and Plan of Merger with Bridg (the “Merger Agreement”), pursuant to which Cardlytics acquired Bridg by merger and assumed all of Bridg’s obligations under the Indemnification Agreement, including pursuant to Section 4.5 of the Merger Agreement;

WHEREAS, DailyGobble, Inc. filed a lawsuit against Mr. Jain and others captioned DailyGobble, Inc. v. Amit Jain, et al.,No. 22STCV15317, in the Superior Court of the State of California (the “DailyGobble Action”);

…

CONFIDENTIAL

RIGHTS OFFERING BACKSTOP AGREEMENT

This RIGHTS OFFERING BACKSTOP AGREEMENT (this “Agreement”), dated September 11, 2026, is made and entered into by and among Rent the Runway, Inc., a Delaware corporation (the “Company”), CHS US Investments LLC, a Cayman limited liability company (the “CHS”), Gateway Runway, LLC, a Delaware limited liability company (“Nexus”), and S3 RR Aggregator, LLC, a Delaware limited liability company (“Story3” and, together with the CHS and Nexus, the “Backstop Purchasers”). The Company and the Backstop Purchasers are each sometimes referred to herein as a “Party” and collectively, as the “Parties.”

…

September 10, 2026

Karyopharm Therapeutics Inc.

85 Wells Avenue, Suite 210

Newton, MA 02459

Attention: Chief Financial Officer

Re:	Fee Agreement Pursuant to Forbearance Agreement

Ladies and Gentlemen:

Karyopharm Therapeutics Inc., a Delaware corporation (the “Company”), agreed, as a condition to the effectiveness of the Forbearance Agreement, dated as of the date hereof, by and among the Company and the Lenders (the “Forbearance Agreement”), to pay certain fees in cash or in the form of series A convertible preferred stock of the Company, par value $0.0001 per share, with an initial liquidation preference of one thousand dollars ($1,000) per share (the “Preferred Stock”), to each of the lenders (the “Lenders”) identified in Schedule I hereto, in an aggregate amount equal to $20,000,000.00, which shall be payable in cash or shares of Preferred Stock.

…

**FORBEARANCE AGREEMENT AND LIMITED WAIVER TO INDENTURES **

This Forbearance Agreement and Limited Waiver to Indentures, dated as of September 10, 2026 (this “Agreement”), is entered into by and among (i) Karyopharm Therapeutics Inc., a Delaware corporation (the “Company”) and each of the undersigned subsidiaries of the Company that have executed and delivered counterpart signature pages to this Agreement (collectively, with the Company, the “Company Parties”); (ii) the undersigned parties that have executed and delivered counterpart signature pages to this Agreement in their respective capacities as Lenders constituting Requisite Lenders under and as defined in the Term Loan Credit Agreement (as defined below) (together with any other Lender that executes a joinder to this Agreement, the “Consenting Term Lenders”); (iii) the undersigned parties that have executed and delivered counterpart signature pages to this Agreement in their respective capacities as persons holding beneficial ownership interests in the Company’s 9.00% Convertible Senior Notes due 2028 (the “*2028 Note

…

---

Exhibit 10.1

Date:	September 11, 2026
To:	NewHold Investment Corp III, a Cayman Islands exempted company with limited liability (“NewHold”), and newcleo plc, a public limited company under the laws of England and Wales (“PubCo”).

…

***SEPARATION AGREEMENT AND RELEASE ***

This SEPARATION AGREEMENT AND RELEASE (the “Agreement”) is entered into by and between Park Hotels & Resorts Inc. (the “Company”) and Thomas C. Morey (“Executive”) (collectively, the “Parties”), and shall be effective as set forth in Section 6(a).

WHEREAS, Executive served as Executive Vice President and Chief Investment Officer as well as General Counsel of the Company;

WHEREAS, Executive’s employment with the Company terminated without Cause on September 8, 2026 (the “Separation Date”);

WHEREAS, Executive is a participant in the Park Hotels & Resorts Inc. Executive Severance Plan (the “Severance Plan”);

**WHEREAS, **the Parties previously entered an Indemnification Agreement effective as of December 20, 2016 (“Indemnification Agreement”); and

WHEREAS, the Company and Executive desire to enter into this Agreement to set out the terms and conditions of Executive’s termination of employment with the Company in accordance with the terms and conditions of the Severance Plan.

…

---

[Execution Version]

CONFIDENTIAL

PUT OPTION AGREEMENT

by and between

SURGEPAYS, INC., as Holder

and

EMERALD SHOALS TARGETED OPPORTUNITIES FUND LP, as Fund

Acknowledged by GPOX

Dated as of September 7, 2026

1

PUT OPTION AGREEMENT (this “Agreement”) is made as of September 7, 2026, by and between SurgePays, Inc., a Nevada corporation (“Holder”), and Emerald Shoals Targeted Opportunities Fund LP, an Ohio limited partnership (“Fund”), and is acknowledged by GPO Plus, Inc., a Nevada corporation (“GPOX”), solely as expressly provided herein. This Agreement is delivered in connection with the Asset Purchase Agreement dated as of September 7, 2026 among Holder, GPOX and ClearLine Apps, LLC (the “Purchase Agreement”). Under the Purchase Agreement, Holder is receiving 25,000,000 shares of GPOX Series D Convertible Preferred Stock solely in satisfaction of the $27,500,000 ClearLine Purchase Price. Fund and/or its affiliates are, as of the date of this Agreement, the largest holder(s) of the common stock of GPOX and, on that ba

…

[Execution Copy]

---

CONFIDENTIAL

**ASSET PURCHASE AGREEMENT **

by and among

**GPO PLUS, INC., as Purchaser **

**CLEARLINE APPS, LLC, as Acquisition Subsidiary **

and

**SURGEPAYS, INC., as Seller **

Dated as of September 7, 2026** **

1

ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of September 7, 2026, by and among GPO Plus, Inc., a Nevada corporation (“GPOX” or “Purchaser”), ClearLine Apps, LLC, a Nevada limited liability company wholly owned by GPOX (“Acquisition Subsidiary”), and SurgePays, Inc., a Nevada corporation (“SURG” or “Seller”).

The parties intend a straightforward asset acquisition between friendly companies. Seller is selling only the Purchased Assets expressly described in this Agreement and the Schedules. Seller is retaining its existing SurgePays-branded wireless and MVNO business and the parties intend that the transaction not disrupt that retained business.

**ARTICLE I **

**PURCHASE AND SALE **

…

Page 1 HOLDER NOTICE AND CONFIRMATION OF EXTENSION OF MATURITY DATE Date: September 9, 2026 To: Attention: From: Re: Nauticus Robotics, Inc. John W. Gibson, Jr., President and Chief Executive Officer; Michael A. Ferrier, General Counsel All Existing Original Issue Discount Senior Secured Convertible Debentures Due September 9, 2026 under the November 4, 2024 Second Amendment and Exchange Agreement Reference is made to all existing Original Issue Discount Senior Secured Convertible Debentures issued by Nauticus Robotics, Inc. (the “Company”) under that certain Second Amendment and Exchange Agreement dated as of November 4, 2024 that (i) are registered in the name of the undersigned Holder, or with respect to which the undersigned has authority to exercise the extension right; (ii) remain outstanding as of the date of this notice; (iii) mature on September 9, 2026; and (iv) have an aggregate outstanding principal amount of $3,985,000 as of the date of this notice (each, a “Debenture” and collectively, the “Debentures”). Capitalized terms not defined in this notice have the meanings ass

…

** **

MEXCO ENERGY CORPORATION AMENDED AND RESTATED
2019 EMPLOYEE INCENTIVE STOCK PLAN

AWARD AGREEMENT

This award agreement (“Award Agreement” or “Agreement”) executed between MEXCO ENERGY CORPORATION (the “Company”), and _________________________(the “Participant”), an employee, director or consultant of the Company or its Subsidiary, regarding a right (the “Option”) awarded to the Participant on ______________________(the “Grant Date”) to purchase from the Company up to but not exceeding in the aggregate ____________shares of Common Stock (as defined in the Mexco Energy Corporation Amended and Restated 2019 Employee Incentive Stock Plan (the “Plan”) at $_____.___ per share (the “Grant Price”), such number of shares and such price per share being subject to adjustment as provided in the Plan, and further subject to the terms and conditions set forth herein.

1. Relationship to Plan.

** **

…

** **

MEXCO ENERGY CORPORATION AMENDED AND RESTATED
2019 EMPLOYEE INCENTIVE STOCK PLAN

AWARD AGREEMENT

This award agreement (“Award Agreement” or “Agreement”) executed between MEXCO ENERGY CORPORATION (the “Company”), and _____________________ (the “Participant”), an employee, director or consultant of the Company or its Subsidiary, regarding a right (the “Option”) awarded to the Participant on ____________________ (the “Grant Date”) to purchase from the Company up to but not exceeding in the aggregate ______ shares of Common Stock (as defined in the Mexco Energy Corporation Amended and Restated 2019 Employee Incentive Stock Plan (the “Plan”) at $_____.___ per share (the “Grant Price”), such number of shares and such price per share being subject to adjustment as provided in the Plan, and further subject to the terms and conditions set forth herein.

1. Relationship to Plan.

** **

…

EXCLUSIVE DISTRIBUTION AND RESELLER AGREEMENT

CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED FROM THIS DOCUMENT BECAUSE IT IS BOTH (A) NOT MATERIAL AND (B) THE TYPE OF INFORMATION THAT THE COMPANY CUSTOMARILY AND ACTUALLY TREATS AS PRIVATE AND CONFIDENTIAL.

EXCLUSIVE DISTRIBUTION AND RESELLER AGREEMENT

(Ophthalmology Genomic Testing Program)

This EXCLUSIVE DISTRIBUTION AND RESELLER AGREEMENT (this “Agreement”) is entered into as of September 3, 2026 (the “Effective Date”), by and between:

…